Psoriasis

Novel Therapeutics Usher in a Year of Innovation
February 22, 2021

Pre- and postmarketing psoriasis studies support novel drug results and new labeling.

Phase 3 Results Support Long-Term Use of Tapinarof Cream
February 18, 2021

Dermavant announces positive results from an interim analysis of its PSOARING 3 safety study investigating tapinarof cream 1% for the treatment of plaque psoriasis in adult patients.

New Year, New drugs for Psoriasis
February 09, 2021

According to one expert, recently completed phase 3 trials of novel drugs have shown impressive results, with 2021 expected to be an exciting year that will bring further advances in treatment options for patients with moderate-to-severe plaque psoriasis.